2022 年第三季度报告 证券代码：688550 证券简称：瑞联新材 西安瑞联新材料股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 291,716,486.46 | -34.59 | 1,188,908,296.26 | 4.92 | | 归属于上市公司股东的 | 48,010,493.49 | -28.49 | 209,180,027.84 | 24.24 | | 净利润 | | | | | | 归属于上市公司股东的 扣除非经常性损益的净 | 44,682,484.02 | -28.34 | 197,577,067.60 | 30.2 ...

2022 年半年度报告 公司代码：688550 公司简称：瑞联新材 西安瑞联新材料股份有限公司 2022 年半年度报告 2022 年 08 月 1 / 190 2022 年半年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险，敬请查阅本报告第三节"管 理层讨论与分析"中"五、风险因素"部分。 三、公司全体董事出席董事会会议。 四、本半年度报告未经审计。 五、公司负责人刘晓春、主管会计工作负责人王银彬及会计机构负责人（会计主管人员）杨博声 明：保证半年度报告中财务报告的真实、准确、完整。 六、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、前瞻性陈述的风险声明 √适用 □不适用 本半年度报告中所涉及的未来计划、发展战略等前瞻性描述，不构成公司对投资者的实质承诺， 敬请投资者注意投资风险。 九、是否存在被控股股东及其关联方非经营性占 ...

Financial Performance - The company's operating revenue for Q1 2022 was CNY 424,905,940.45, representing a year-on-year increase of 38.00%[5] - The net profit attributable to shareholders for Q1 2022 was CNY 79,802,876.73, reflecting a growth of 57.91% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 75,767,720.15, which is an increase of 77.76% year-on-year[5] - Basic earnings per share for Q1 2022 were CNY 1.14, up by 58.33% from the previous year[6] - Operating profit for Q1 2022 was ¥94,129,696.43, representing a 64.1% increase from ¥57,371,869.45 in Q1 2021[21] - The company recorded investment income of ¥2,193,290.08 in Q1 2022, significantly up from ¥360,547.95 in Q1 2021[20] Research and Development - The total R&D investment for the quarter was CNY 25,170,457.99, marking a 42.28% increase compared to the same period last year[6] - The R&D investment accounted for 5.92% of the operating revenue, an increase of 0.17 percentage points year-on-year[6] - Research and development expenses increased to ¥25,170,457.99 in Q1 2022, up 42.1% from ¥17,691,399.07 in Q1 2021[20] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -7,126,238.62, indicating increased expenditures on inventory and employee compensation[9] - Cash flow from operating activities showed a net outflow of ¥7,126,238.62 in Q1 2022, compared to a net inflow of ¥56,347,358.86 in Q1 2021[24] - The company reported cash and cash equivalents of ¥551,481,127.77 at the end of Q1 2022, down from ¥1,231,535,921.34 at the end of Q1 2021[25] Assets and Liabilities - The company's total assets at the end of the quarter were CNY 3,842,175,437.85, a slight increase of 0.30% from the end of the previous year[6] - As of March 31, 2022, the total current assets amounted to RMB 2,789,848,248.58, a decrease from RMB 2,851,132,436.31 at the end of 2021, reflecting a decline of approximately 2.15%[15] - The total liabilities decreased to RMB 904,360,331.39 from RMB 975,934,344.63, indicating a reduction of approximately 7.31%[17] - The total assets as of March 31, 2022, were RMB 3,842,175,437.85, compared to RMB 3,830,563,570.89 at the end of 2021, representing a marginal increase of about 0.31%[17] - The company's inventory increased to RMB 596,724,309.72 from RMB 527,762,046.22, marking an increase of approximately 13.06%[15] - The accounts receivable slightly decreased to RMB 302,303,638.19 from RMB 306,951,169.50, reflecting a decline of about 1.08%[15] - The company's retained earnings rose to RMB 644,883,704.27 from RMB 565,080,827.54, indicating an increase of approximately 14.06%[17] - The non-current assets totaled RMB 1,052,327,189.27, up from RMB 979,431,134.58, which is an increase of about 7.43%[16] - The short-term borrowings increased to RMB 365,021,500.00 from RMB 302,956,978.40, reflecting an increase of approximately 20.49%[16] - The company's total equity increased to RMB 2,937,815,106.46 from RMB 2,854,629,226.26, representing an increase of about 2.91%[17] Operating Costs - Total operating costs for Q1 2022 were ¥337,041,290.00, a 35.4% increase from ¥248,967,332.52 in Q1 2021[20] - The sales revenue from display materials increased by 51% year-on-year, driven by significant growth in sales to foreign customers[9]

Financial Performance - The company's operating revenue for 2021 was CNY 1,525,576,435.25, representing a 45.35% increase compared to CNY 1,049,609,791.38 in 2020[21]. - The net profit attributable to shareholders for 2021 was CNY 239,777,318.88, a 36.70% increase from CNY 175,409,496.69 in 2020[21]. - The net profit after deducting non-recurring gains and losses was CNY 214,021,934.61, up 32.98% from CNY 160,947,289.88 in 2020[21]. - The total assets at the end of 2021 reached CNY 3,830,563,570.89, a 30.97% increase from CNY 2,924,772,421.71 at the end of 2020[21]. - The company's net assets attributable to shareholders increased by 6.05% to CNY 2,854,629,226.26 at the end of 2021[21]. - The basic earnings per share for 2021 was CNY 3.42, a 14.00% increase from CNY 3.00 in 2020[22]. - The overall gross margin for 2021 was 35%, a decrease of 5 percentage points compared to 2020, primarily due to increased costs from raw materials and currency fluctuations[36]. - The company achieved a total revenue of 4,298 million RMB, with a net profit of 2,012.16 million RMB, representing a significant increase compared to the previous year[80]. - The company reported a significant increase in revenue, achieving a total of $1.5 billion for the fiscal year, representing a 20% year-over-year growth[180]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 17.00 CNY per 10 shares, totaling approximately 119.31 million CNY, which represents 49.76% of the net profit attributable to shareholders for the year[5]. - The total number of shares held by directors, supervisors, and senior management at the beginning of the year was 8,776,160, with a decrease of 2,600 shares by the end of the year[178]. - The company approved the use of excess raised funds for construction projects, including the pharmaceutical raw material project in Weinan[172]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to RMB 5.2986 million[193]. Research and Development - Research and development expenses accounted for 5.46% of operating revenue, an increase of 1.43 percentage points from 4.03% in 2020[22]. - The company achieved a total R&D investment of ¥83,305,087.43, representing a significant increase of 96.93% compared to the previous year[76]. - The total number of R&D personnel reached 369, an increase of 174 compared to the end of 2020[44]. - The company completed a total of 479 R&D projects during the reporting period, including 106 pharmaceutical projects[44]. - The company has developed 5 new furan-derived materials that enhance the luminous efficiency of OLED panels, contributing to improved product performance[79]. - The company is enhancing management efficiency through automation and information technology, aiming to improve production efficiency and safety management[158]. Market and Sales Performance - The company's foreign sales revenue was 155.78 million USD, a year-on-year increase of 5.87 million USD, accounting for 65% of total revenue[36]. - The OLED segment generated sales revenue of 437.30 million RMB, accounting for 28.66% of total revenue, with a year-on-year increase of 54.91%[37]. - The liquid crystal segment achieved sales revenue of 764.82 million RMB, representing 50.13% of total revenue, with a year-on-year increase of 59.40%[40]. - The company is focused on expanding its customer base to mitigate risks associated with high customer concentration[91]. - The company plans to continue expanding its domestic market and enhancing refined management to drive future growth[32]. Governance and Compliance - The board of directors and management have confirmed the accuracy and completeness of the annual report[4]. - The company has not violated any decision-making procedures regarding external guarantees[8]. - The company has established a governance structure consisting of a shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and compliance with relevant laws and regulations[169]. - There were no significant differences between the company's governance practices and the regulations set by the China Securities Regulatory Commission[169]. - The company did not report any issues regarding independence or operational autonomy from its controlling shareholders[169]. Operational Efficiency and Challenges - The company experienced significant growth in sales orders, contributing to the overall revenue increase[22]. - The company faces risks related to raw material price fluctuations, which could adversely affect profitability[93]. - The company is actively monitoring exchange rate fluctuations to manage potential impacts on overseas revenue[95]. - The company has implemented a systematic approach to control chiral isomer impurities, achieving a maximum of 21 reaction steps and 7 types of isomer impurity control[71]. - The company plans to strengthen inventory management and reduce the growth rate of finished goods and raw material inventory in 2022[165]. Future Outlook - The company provided guidance for the next fiscal year, projecting revenue growth of 25% and aiming to reach $1.875 billion[180]. - The company plans to invest 400 million CNY in major projects, including the completion of the OLED production project by Q4 2022[161]. - The company aims for a project success rate of over 90% and a pilot project success rate of over 95% in 2022[162]. - The company anticipates continued growth in OLED products, but will adjust inventory based on customer demand and technology trends[164]. - The company is exploring acquisition opportunities to enhance its product portfolio, targeting firms with complementary technologies[182].

Financial Performance - Revenue for Q3 2021 reached ¥446,014,583.84, an increase of 75.69% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2021 was ¥67,135,345.58, up 62.97% year-on-year[5] - Basic earnings per share for Q3 2021 were ¥0.96, reflecting a 37.14% increase year-on-year[6] - Total operating revenue for the first three quarters of 2021 reached ¥1,133,206,981.44, a significant increase of 55.8% compared to ¥727,256,346.02 in the same period of 2020[20] - Net profit for the first three quarters of 2021 was ¥168,362,144.72, representing a 36.4% increase from ¥123,454,188.39 in the same period of 2020[21] - Earnings per share for the first three quarters of 2021 were ¥2.40, compared to ¥2.26 in the same period of 2020[22] Research and Development - R&D investment totaled ¥22,936,057.78 in Q3 2021, representing a 135.82% increase compared to the same period last year[6] - Research and development expenses for the first three quarters of 2021 were ¥58,903,570.26, up from ¥25,635,216.09 in the same period of 2020, indicating a focus on innovation[20] Assets and Liabilities - The company's total assets as of the end of Q3 2021 were ¥3,294,125,003.78, a 12.63% increase from the end of the previous year[6] - As of September 30, 2021, the total current assets amounted to ¥2,468,431,274.14, an increase from ¥2,303,294,205.57 in the previous year[14] - Total assets reached ¥3,294,125,003.78, up from ¥2,924,772,421.71, marking an increase of around 12.6%[16] - The company's total liabilities as of the end of the third quarter of 2021 amounted to ¥513,967,368.25, compared to ¥232,976,930.90 at the end of the same period in 2020[20] - The company reported a significant increase in accounts payable, which rose to ¥258,736,799.96 from ¥126,101,275.67, a growth of about 105%[16] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥136,440,952.99, showing a 32.01% increase[6] - In the first three quarters of 2021, the company generated cash inflows from operating activities amounting to ¥967,776,388.16, a significant increase from ¥618,573,527.97 in the same period of 2020, representing a growth of approximately 56.4%[24] - The net cash flow from operating activities for the first three quarters of 2021 was ¥136,440,952.99, compared to ¥103,354,776.29 in 2020, indicating an increase of about 32.0%[24] - The company reported cash inflows from investment activities totaling ¥686,741,634.57, a substantial rise from ¥17,733.43 in the previous year[25] - Cash outflows for investment activities reached ¥1,057,431,949.13, compared to ¥81,370,221.38 in the same period of 2020, resulting in a net cash flow from investment activities of -¥370,690,314.56[25] - The company experienced a net cash outflow from financing activities of -¥145,066,274.14, contrasting sharply with a net inflow of ¥1,582,393,710.73 in the previous year[25] Shareholder Information - The company reported a total of 8,437 common shareholders at the end of the reporting period[12] - Total equity attributable to shareholders reached ¥2,780,157,635.53, an increase from ¥2,691,795,490.81 in the previous year[20] Inventory and Receivables - Accounts receivable increased significantly to ¥364,872,158.55, up from ¥235,614,211.26, representing a growth of about 55%[14] - Inventory rose to ¥503,274,730.91, compared to ¥301,927,486.02 in the previous year, indicating an increase of approximately 67%[14] Other Information - The company has not reported any new product developments or market expansion strategies during this quarter[14] - There are no significant mergers or acquisitions reported in the current financial period[14] - The weighted average return on equity decreased by 7.01 percentage points to 6.14% year-to-date[6] - Deferred income tax liabilities increased to ¥901,564.09 from ¥142,502.39 year-over-year, reflecting changes in tax obligations[20] - The company paid out ¥80,000,000.00 in dividends and interest during the first three quarters of 2021, compared to ¥11,588,771.59 in the previous year[25]

Financial Performance - The company reported a total revenue of 500 million CNY for the first half of 2021, representing a year-on-year increase of 20%[14]. - The company's operating revenue for the first half of 2021 reached approximately RMB 687.19 million, representing a 45.16% increase compared to RMB 473.39 million in the same period last year[24]. - The net profit attributable to shareholders for the same period was approximately RMB 101.23 million, an increase of 23.06% from RMB 82.26 million year-on-year[24]. - The company achieved a revenue of 687.19 million yuan in the first half of 2021, representing a year-on-year growth of 45%[60]. - Net profit attributable to shareholders was 101.23 million yuan, up 23% year-on-year, while the net profit after deducting non-recurring items was 89.39 million yuan, a 10% increase[60]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion in the first half of 2021, representing a 20% year-over-year growth[129]. - The company reported a significant increase in revenue, achieving a total of $500 million for the quarter, representing a 25% year-over-year growth[136]. User Growth and Market Expansion - The company has expanded its user base by 15%, reaching a total of 1.2 million active users[14]. - User data showed an increase in active users to 5 million, up from 4.5 million in the previous quarter, marking an 11% growth[120]. - The company is considering strategic acquisitions to bolster its market position, with a budget of 100 million allocated for potential deals[120]. - Market expansion plans include entering two new international markets by the end of 2021[14]. - The company plans to enhance its digital marketing strategy, aiming for a 30% increase in online sales[119]. - The company is expanding its market presence in Asia, targeting a 25% increase in market share by the end of 2024[127]. Research and Development - The company is investing 50 million CNY in R&D for new OLED materials, aiming to enhance product performance[14]. - Research and development expenses accounted for 5.23% of operating revenue, an increase of 1.87 percentage points compared to the previous year[21]. - The company has completed a total of 249 projects related to new product development and process optimization in the first half of 2021[42]. - Research and development expenses increased by 126.08% year-on-year, totaling approximately ¥35.97 million, which represents 5.23% of operating revenue[44][45]. - The company is investing heavily in R&D, allocating 200 million towards the development of new technologies and products[133]. Profitability and Cost Management - The gross profit margin improved to 35%, up from 30% in the same period last year[14]. - The gross profit margin decreased to 35.04%, down 7.74% year-on-year, primarily due to rising raw material costs and currency exchange losses[60][61]. - The gross margin improved to 45%, up from 42% in the previous year, reflecting better cost management[118]. - The company has committed to reducing operational costs by 15% through efficiency improvements and technology upgrades[131]. Strategic Acquisitions and Partnerships - The company has completed a strategic acquisition of a local competitor for 100 million CNY to enhance market share[14]. - A new partnership with a leading tech firm is expected to drive innovation and improve product offerings[120]. - The company announced a strategic acquisition of a competitor for $200 million, expected to enhance its product offerings[127]. Financial Position and Assets - The total assets of the company increased by 9.05% to approximately RMB 3.19 billion from RMB 2.92 billion at the end of the previous year[24]. - The company's total assets amount to 2,713,022,289.9[199]. - The company's total current assets reached CNY 2,436,737,716.74 as of June 30, 2021, compared to CNY 2,303,294,205.57 at the end of 2020, indicating an increase of about 5.79%[171]. Risks and Challenges - The company has identified potential risks including supply chain disruptions and has outlined mitigation strategies[4]. - The pharmaceutical CDMO segment experienced a revenue decline of 26% to 101.38 million yuan, attributed to delays in clinical trials due to the pandemic[68]. - The company has faced delays in project progress due to factors such as limited self-funding before the arrival of raised funds and the impact of the COVID-19 pandemic on project approvals and construction[149]. Shareholder Information - The total number of ordinary shareholders as of the reporting period end is 9,718[157]. - The largest shareholder, Beijing Zhuoshihengli Investment Fund Management Center, holds 13,697,288 shares, accounting for 19.52% of total shares[159]. - The company has established relationships among several shareholders, indicating potential coordinated actions in decision-making[163].

2021 年第一季度报告 公司代码：688550 公司简称：瑞联新材 西安瑞联新材料股份有限公司 2021 年第一季度报告 1 / 24 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 7 | | 四、 | 附录 10 | 2021 年第一季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 未出席董事情况 | | 本报告期末 | 上年度末 | 本报告期末比上年度 | | --- | --- | --- | --- | | | | | 末增减(%) | | 总资产 | 3,080,651,470.94 | 2,924,772,421.71 | 5.33 | | 归属于上市公 司股东的净资 | 2,742,332,071.85 | 2,691,795,490.81 | 1.88 | | 产 | | | | | | 年初至报告期末 | 上年初至上年报告期 | 比上年同期增减(%) | | | | 末 | ...

公司代码：688550 公司简称：瑞联新材 2020 年年度报告 三、 公司全体董事出席董事会会议。 四、 立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 五、 公司负责人刘晓春、主管会计工作负责人王银彬及会计机构负责人（会计主管人员）曹夏璐 声明：保证年度报告中财务报告的真实、准确、完整。 六、 经董事会审议的报告期利润分配预案或公积金转增股本预案 西安瑞联新材料股份有限公司 2020 年年度报告 2 / 251 2020 年年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险及应对措施， 敬请查阅本报告第四节"经营情况讨论与分析"，敬请广大投资者仔细阅读并注意投 资风险。 经公司第二届董事会第十九次会议审议，公司拟以实施权益分派股权登记日登 记的总股本为基数，向全体股东每10股派发现金红利11.40元（含税），总派发现金 红利人民币80,000,000元（含税），不进行资本公积金 ...

2020 年第三季度报告 公司代码：688550 公司简称：瑞联新材 西安瑞联新材料股份有限公司 2020 年第三季度报告 1 / 28 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 8 | | 四、 | 附录 | 10 | 2020 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人刘晓春、主管会计工作负责人王银彬及会计机构负责人（会计主管人员）曹夏璐 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 3 / 28 单位：元币种：人民币 本报告期末 上年度末 本报告期末比上年度末增 减(%) 总资产 2,863,060,280.61 1,239,019,917.94 131.07 归属于上市公司 股东的净资 ...